Craig Gracey Sells 6,894 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health, Inc. (NASDAQ:OMDA) CAO Craig Gracey sold 6,894 shares of the company’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $17.42, for a total value of $120,093.48. Following the completion of the transaction, the chief accounting officer directly owned 9,191 shares in the company, valued at approximately $160,107.22. This trade represents a 42.86% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Omada Health Stock Up 0.8%

Shares of Omada Health stock opened at $17.25 on Thursday. Omada Health, Inc. has a 52 week low of $10.28 and a 52 week high of $26.92. The business’s fifty day simple moving average is $15.63 and its 200-day simple moving average is $14.79. The firm has a market cap of $1.03 billion and a PE ratio of -63.89.

Omada Health (NASDAQ:OMDA) last announced its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The business had revenue of $78.05 million for the quarter. As a group, equities analysts expect that Omada Health, Inc. will post -0.01 earnings per share for the current year.

Institutional Investors Weigh In On Omada Health

Large investors have recently bought and sold shares of the stock. BIT Capital GmbH purchased a new stake in Omada Health during the 3rd quarter worth about $13,639,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Omada Health during the 4th quarter worth about $1,222,000. Divisadero Street Capital Management LP purchased a new stake in Omada Health during the 3rd quarter worth about $30,510,000. a16z Perennial Management L.P. purchased a new stake in Omada Health during the 4th quarter worth about $2,480,000. Finally, Madryn Asset Management LP purchased a new stake in Omada Health during the 4th quarter worth about $9,212,000.

Analysts Set New Price Targets

Several research firms recently issued reports on OMDA. Wall Street Zen lowered Omada Health from a “buy” rating to a “hold” rating in a research note on Saturday, May 30th. Evercore reissued an “outperform” rating and set a $20.00 target price on shares of Omada Health in a research note on Friday, May 8th. Wells Fargo & Company increased their target price on Omada Health from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Friday, May 8th. Citigroup reissued an “outperform” rating on shares of Omada Health in a research note on Friday, May 8th. Finally, Needham & Company LLC reissued a “buy” rating and set a $28.00 target price on shares of Omada Health in a research note on Friday, May 8th. Ten investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $22.91.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.